The use of microRNAs as biomarkers for early cancer detection has shown great potential, with particular miRNA signatures being able to accurately diagnose difficult-to-detect cancers. Technological advances in biosensor development and machine learning have aided in the identification and clinical validation of these miRNA signatures.
Previous ArticleAsia Pacific Iot Security Market Cagr Of 27.0%, Cracking The Code Of Audience Odyssey Key Steps To Market Identification
Next Article Aptos Ceo Appointed To Cftc’s Digital Asset Group